dr. schmid on challenges concerning biosimilars in oncology
Published 5 years ago • 96 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
0:54
dr. schmid on the role of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
6:07
manufacturing of biologics
-
3:00
biosimilars: complex copycat drugs
-
7:21
biologic drugs and biosimilars
-
5:56
the complexity of choosing biosimilars in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
1:45
dr. weise discusses challenges with biosimilar acceptance in oncology
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
1:17
dr. lyman on educating physicians about biosimilars in oncology
-
1:08
dr. tripathy on the progression of biosimilars in oncology
-
1:21
dr. denes discusses biosimilar pricing in oncology